Basic Information
ID: ALA2050901
Type: Binding
Description: Inhibition of COX2 in LPS-stimulated human whole blood assessed as residual PGF2alpha level at 100 uM preincubated for 15 mins prior to LPS-stimulation measured after 24 hrs by LC-MS/MS analysis relative to control
Organism: Homo sapiens
Tissue: Blood
Activity Charts
Bioactivity
Activity Types for Assay ALA2050901
Activity
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 542.47 | 7.62 | 7.62 |
| 538.05 | 6.98 | 6.98 |
| 508.02 | 6.97 | 6.97 |
| 466.37 | 5.96 | 5.96 |
| 466.37 | 5.96 | 5.96 |
| 484.36 | 6.10 | 6.10 |
| 445.95 | 5.61 | 5.61 |
| 542.47 | 7.62 | 7.62 |